nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine triphosphate—ABCB11—Cyclosporine—psoriasis	0.0976	0.206	CbGbCtD
Adenosine triphosphate—ABCC2—Mycophenolate mofetil—psoriasis	0.0677	0.143	CbGbCtD
Adenosine triphosphate—ABCB11—Dexamethasone—psoriasis	0.0643	0.136	CbGbCtD
Adenosine triphosphate—ABCC2—Cyclosporine—psoriasis	0.0513	0.108	CbGbCtD
Adenosine triphosphate—ACVR1—pes—psoriasis	0.0339	0.19	CbGeAlD
Adenosine triphosphate—ABCC2—Dexamethasone—psoriasis	0.0338	0.0714	CbGbCtD
Adenosine triphosphate—ABCC2—Methotrexate—psoriasis	0.0272	0.0574	CbGbCtD
Adenosine triphosphate—ARAF—vertebral column—psoriasis	0.0246	0.138	CbGeAlD
Adenosine triphosphate—ABCB1—Mycophenolate mofetil—psoriasis	0.0221	0.0466	CbGbCtD
Adenosine triphosphate—ABCB1—Betamethasone—psoriasis	0.0189	0.04	CbGbCtD
Adenosine triphosphate—ABCB1—Prednisolone—psoriasis	0.0187	0.0395	CbGbCtD
Adenosine triphosphate—ABCB1—Hydrocortisone—psoriasis	0.0177	0.0374	CbGbCtD
Adenosine triphosphate—ABCB1—Prednisone—psoriasis	0.0176	0.0373	CbGbCtD
Adenosine triphosphate—ABCB1—Cyclosporine—psoriasis	0.0167	0.0353	CbGbCtD
Adenosine triphosphate—ACVRL1—endothelium—psoriasis	0.0125	0.0704	CbGeAlD
Adenosine triphosphate—ABCB1—Dexamethasone—psoriasis	0.011	0.0233	CbGbCtD
Adenosine triphosphate—AKT1—skin epidermis—psoriasis	0.00925	0.052	CbGeAlD
Adenosine triphosphate—ABCB1—Methotrexate—psoriasis	0.00885	0.0187	CbGbCtD
Adenosine triphosphate—AKT1—endothelium—psoriasis	0.00671	0.0377	CbGeAlD
Adenosine triphosphate—ADRBK2—tendon—psoriasis	0.00449	0.0252	CbGeAlD
Adenosine triphosphate—ASNA1—skin of body—psoriasis	0.00438	0.0246	CbGeAlD
Adenosine triphosphate—AFG3L2—skin of body—psoriasis	0.00432	0.0243	CbGeAlD
Adenosine triphosphate—NAE1—skin of body—psoriasis	0.00422	0.0237	CbGeAlD
Adenosine triphosphate—ABCG1—tendon—psoriasis	0.00407	0.0229	CbGeAlD
Adenosine triphosphate—ACVRL1—tendon—psoriasis	0.00407	0.0229	CbGeAlD
Adenosine triphosphate—HSPA1A—tendon—psoriasis	0.0038	0.0213	CbGeAlD
Adenosine triphosphate—HSPA1B—tendon—psoriasis	0.0038	0.0213	CbGeAlD
Adenosine triphosphate—ARAF—tendon—psoriasis	0.00355	0.02	CbGeAlD
Adenosine triphosphate—ABCA1—skin of body—psoriasis	0.00345	0.0194	CbGeAlD
Adenosine triphosphate—ACSS2—skin of body—psoriasis	0.00334	0.0188	CbGeAlD
Adenosine triphosphate—ASNA1—tendon—psoriasis	0.00333	0.0187	CbGeAlD
Adenosine triphosphate—AFG3L2—tendon—psoriasis	0.00329	0.0185	CbGeAlD
Adenosine triphosphate—NAE1—tendon—psoriasis	0.00321	0.018	CbGeAlD
Adenosine triphosphate—SLC25A4—tendon—psoriasis	0.00299	0.0168	CbGeAlD
Adenosine triphosphate—AKT1—skin of body—psoriasis	0.00287	0.0161	CbGeAlD
Adenosine triphosphate—ACSS1—tendon—psoriasis	0.00265	0.0149	CbGeAlD
Adenosine triphosphate—NT5C2—tendon—psoriasis	0.0026	0.0146	CbGeAlD
Adenosine triphosphate—ACVR1—tendon—psoriasis	0.0026	0.0146	CbGeAlD
Adenosine triphosphate—ACSS2—tendon—psoriasis	0.00254	0.0143	CbGeAlD
Adenosine triphosphate—ACSL1—tendon—psoriasis	0.00253	0.0142	CbGeAlD
Adenosine triphosphate—ASS1—skin of body—psoriasis	0.0025	0.014	CbGeAlD
Adenosine triphosphate—ABL2—tendon—psoriasis	0.00248	0.0139	CbGeAlD
Adenosine triphosphate—ADK—skin of body—psoriasis	0.00218	0.0123	CbGeAlD
Adenosine triphosphate—AKT1—tendon—psoriasis	0.00218	0.0123	CbGeAlD
Adenosine triphosphate—ASNS—tendon—psoriasis	0.00218	0.0123	CbGeAlD
Adenosine triphosphate—ASS1—tendon—psoriasis	0.0019	0.0107	CbGeAlD
Adenosine triphosphate—ADK—tendon—psoriasis	0.00166	0.00934	CbGeAlD
Adenosine triphosphate—ABL1—skin of body—psoriasis	0.00157	0.00883	CbGeAlD
Adenosine triphosphate—HSPA1A—Mycophenolate mofetil—Mycophenolic acid—psoriasis	0.00126	0.079	CbGdCrCtD
Adenosine triphosphate—ABL1—tendon—psoriasis	0.0012	0.00672	CbGeAlD
Adenosine triphosphate—ABCC2—tendon—psoriasis	0.00103	0.00581	CbGeAlD
Adenosine triphosphate—SLC25A4—Vitamin A—Acitretin—psoriasis	0.000874	0.0547	CbGdCrCtD
Adenosine triphosphate—AKT1—Mycophenolic acid—Mycophenolate mofetil—psoriasis	0.000838	0.0525	CbGdCrCtD
Adenosine triphosphate—AKT1—Alitretinoin—Acitretin—psoriasis	0.000637	0.0399	CbGdCrCtD
Adenosine triphosphate—AKT1—Tretinoin—Acitretin—psoriasis	0.000637	0.0399	CbGdCrCtD
Adenosine triphosphate—AKT1—Isotretinoin—Acitretin—psoriasis	0.000637	0.0399	CbGdCrCtD
Adenosine triphosphate—SLC25A4—Isotretinoin—Acitretin—psoriasis	0.000611	0.0383	CbGdCrCtD
Adenosine triphosphate—SLC25A4—Alitretinoin—Acitretin—psoriasis	0.000611	0.0383	CbGdCrCtD
Adenosine triphosphate—SLC25A4—Tretinoin—Acitretin—psoriasis	0.000611	0.0383	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Isotretinoin—Acitretin—psoriasis	0.000542	0.0339	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Alitretinoin—Acitretin—psoriasis	0.000542	0.0339	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Tretinoin—Acitretin—psoriasis	0.000542	0.0339	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Clobetasol propionate—psoriasis	0.000226	0.0142	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Clobetasol propionate—psoriasis	0.000226	0.0142	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Beclomethasone—psoriasis	0.000181	0.0114	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Fluocinonide—psoriasis	0.000181	0.0114	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Fluocinonide—psoriasis	0.000181	0.0114	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Beclomethasone—psoriasis	0.000181	0.0114	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Fluocinolone Acetonide—psoriasis	0.000176	0.011	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.000176	0.011	CbGdCrCtD
Adenosine triphosphate—NAE1—Levonorgestrel—Hydrocortisone—psoriasis	0.000174	0.0109	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Clobetasol propionate—psoriasis	0.000162	0.0101	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000158	0.00988	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Fluocinonide—psoriasis	0.000156	0.00976	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Fluocinolone Acetonide—psoriasis	0.000151	0.00949	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Clobetasol propionate—psoriasis	0.000149	0.00934	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Clobetasol propionate—psoriasis	0.000149	0.00931	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Clobetasol propionate—psoriasis	0.000131	0.00819	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Beclomethasone—psoriasis	0.00013	0.00812	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Fluocinonide—psoriasis	0.00013	0.00812	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Fluocinonide—psoriasis	0.000126	0.00791	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Beclomethasone—psoriasis	0.000126	0.00791	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Fluocinolone Acetonide—psoriasis	0.000126	0.00789	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000123	0.00769	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Fluocinonide—psoriasis	0.000119	0.00748	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Beclomethasone—psoriasis	0.000119	0.00748	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Fluocinonide—psoriasis	0.000119	0.00746	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Beclomethasone—psoriasis	0.000119	0.00746	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Fluocinolone Acetonide—psoriasis	0.000116	0.00727	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Fluocinonide—psoriasis	0.000105	0.00656	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Beclomethasone—psoriasis	0.000105	0.00656	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Fluocinolone Acetonide—psoriasis	0.000102	0.00637	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Hydrocortisone—psoriasis	8.9e-05	0.00558	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Hydrocortisone—psoriasis	8.9e-05	0.00558	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Betamethasone—psoriasis	8.26e-05	0.00518	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Dexamethasone—psoriasis	8.26e-05	0.00518	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Triamcinolone—psoriasis	8.07e-05	0.00506	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Triamcinolone—psoriasis	8.07e-05	0.00506	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Clobetasol propionate—psoriasis	7.99e-05	0.00501	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Clobetasol propionate—psoriasis	7.99e-05	0.00501	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Prednisone—psoriasis	7.66e-05	0.0048	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Prednisone—psoriasis	7.66e-05	0.0048	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Hydrocortisone—psoriasis	7.65e-05	0.00479	CbGdCrCtD
Adenosine triphosphate—ACVR1—Dexamethasone—Prednisolone—psoriasis	7.48e-05	0.00469	CbGdCrCtD
Adenosine triphosphate—ACVR1—Betamethasone—Prednisolone—psoriasis	7.48e-05	0.00469	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Betamethasone—psoriasis	7.1e-05	0.00445	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Dexamethasone—psoriasis	7.1e-05	0.00445	CbGdCrCtD
Adenosine triphosphate—ASS1—Norethindrone—Hydrocortisone—psoriasis	6.6e-05	0.00413	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Flurandrenolide—Prednisolone—psoriasis	6.43e-05	0.00403	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Beclomethasone—psoriasis	6.4e-05	0.00401	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Fluocinonide—psoriasis	6.4e-05	0.00401	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Beclomethasone—psoriasis	6.4e-05	0.00401	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Fluocinonide—psoriasis	6.4e-05	0.00401	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Hydrocortisone—psoriasis	6.36e-05	0.00398	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Fluocinolone Acetonide—psoriasis	6.22e-05	0.0039	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Fluocinolone Acetonide—psoriasis	6.22e-05	0.0039	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Betamethasone—psoriasis	5.9e-05	0.0037	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Dexamethasone—psoriasis	5.9e-05	0.0037	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Betamethasone—psoriasis	5.76e-05	0.00361	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Dexamethasone—psoriasis	5.76e-05	0.00361	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluticasone Propionate—Triamcinolone—psoriasis	5.62e-05	0.00352	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Prednisone—psoriasis	5.47e-05	0.00343	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Dexamethasone—psoriasis	5.44e-05	0.00341	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Betamethasone—psoriasis	5.44e-05	0.00341	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Dexamethasone—psoriasis	5.42e-05	0.0034	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Betamethasone—psoriasis	5.42e-05	0.0034	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Triamcinolone—Prednisolone—psoriasis	5.34e-05	0.00335	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Triamcinolone—psoriasis	5.32e-05	0.00333	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Triamcinolone—psoriasis	5.3e-05	0.00332	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Hydrocortisone—psoriasis	5.14e-05	0.00322	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Diflorasone—Prednisone—psoriasis	5.04e-05	0.00316	CbGdCrCtD
Adenosine triphosphate—ABL1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.97e-05	0.000149	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Metabolism—APOE—psoriasis	4.94e-05	0.000148	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Diflorasone—Prednisolone—psoriasis	4.92e-05	0.00309	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Fluocinolone Acetonide—Prednisolone—psoriasis	4.91e-05	0.00308	CbGdCrCtD
Adenosine triphosphate—AKT1—Signaling by NGF—NFKB1—psoriasis	4.88e-05	0.000147	CbGpPWpGaD
Adenosine triphosphate—AKT1—Downstream signal transduction—IL6—psoriasis	4.85e-05	0.000146	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by NGF—IL6—psoriasis	4.85e-05	0.000146	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—NOS2—psoriasis	4.84e-05	0.000146	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by FGFR—IL6—psoriasis	4.83e-05	0.000145	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—HLA-A—psoriasis	4.82e-05	0.000145	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—HLA-A—psoriasis	4.81e-05	0.000145	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by ERBB2—IL6—psoriasis	4.8e-05	0.000144	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—CRP—psoriasis	4.78e-05	0.000144	CbGpPWpGaD
Adenosine triphosphate—AKT1—DAP12 signaling—IL6—psoriasis	4.78e-05	0.000144	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—JUN—psoriasis	4.77e-05	0.000143	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Budesonide—Betamethasone—psoriasis	4.77e-05	0.00299	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Budesonide—Dexamethasone—psoriasis	4.77e-05	0.00299	CbGdCrCtD
Adenosine triphosphate—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.71e-05	0.000142	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Budesonide—Triamcinolone—psoriasis	4.66e-05	0.00292	CbGdCrCtD
Adenosine triphosphate—AKT1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.62e-05	0.000139	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—HLA-A—psoriasis	4.62e-05	0.000139	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—PPARG—psoriasis	4.61e-05	0.000139	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—CRP—psoriasis	4.6e-05	0.000138	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—NFKB1—psoriasis	4.59e-05	0.000138	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—NOS2—psoriasis	4.59e-05	0.000138	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—JUN—psoriasis	4.57e-05	0.000137	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—STAT3—psoriasis	4.54e-05	0.000137	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—CRP—psoriasis	4.53e-05	0.000136	CbGpPWpGaD
Adenosine triphosphate—AKT1—DAP12 interactions—IL6—psoriasis	4.5e-05	0.000135	CbGpPWpGaD
Adenosine triphosphate—AKT1—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	4.5e-05	0.000135	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by FGFR in disease—IL6—psoriasis	4.5e-05	0.000135	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by EGFR—IL6—psoriasis	4.46e-05	0.000134	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—HLA-A—psoriasis	4.45e-05	0.000134	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Budesonide—Prednisone—psoriasis	4.42e-05	0.00277	CbGdCrCtD
Adenosine triphosphate—AKT1—Immune System—HLA-E—psoriasis	4.42e-05	0.000133	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by EGFR in Cancer—IL6—psoriasis	4.42e-05	0.000133	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—CARM1—psoriasis	4.41e-05	0.000133	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—CRP—psoriasis	4.41e-05	0.000132	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—NFKB1—psoriasis	4.4e-05	0.000132	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—HLA-DRB1—psoriasis	4.4e-05	0.000132	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—HLA-DRB1—psoriasis	4.4e-05	0.000132	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by PDGF—IL6—psoriasis	4.4e-05	0.000132	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—STAT3—psoriasis	4.38e-05	0.000132	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.38e-05	0.000132	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—CXCL8—psoriasis	4.38e-05	0.000132	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—PPARG—psoriasis	4.37e-05	0.000131	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—NFKBIA—psoriasis	4.36e-05	0.000131	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Allograft Rejection—TNF—psoriasis	4.34e-05	0.000131	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—NDUFA5—psoriasis	4.34e-05	0.00013	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CCL20—psoriasis	4.34e-05	0.00013	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	4.32e-05	0.00013	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Budesonide—Prednisolone—psoriasis	4.32e-05	0.00271	CbGdCrCtD
Adenosine triphosphate—ABCA1—Metabolism—PPARG—psoriasis	4.3e-05	0.000129	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—CAT—psoriasis	4.29e-05	0.000129	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—SOCS1—psoriasis	4.28e-05	0.000129	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—HLA-A—psoriasis	4.26e-05	0.000128	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—ICAM1—psoriasis	4.22e-05	0.000127	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—HLA-DRB1—psoriasis	4.22e-05	0.000127	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—ICAM1—psoriasis	4.22e-05	0.000127	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—STAT3—psoriasis	4.19e-05	0.000126	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-E—psoriasis	4.19e-05	0.000126	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—NFKBIA—psoriasis	4.19e-05	0.000126	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—NFKBIA—psoriasis	4.19e-05	0.000126	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—APOE—psoriasis	4.15e-05	0.000125	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—NFKBIA—psoriasis	4.13e-05	0.000124	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—JUN—psoriasis	4.07e-05	0.000122	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—ICAM1—psoriasis	4.05e-05	0.000122	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—TYK2—psoriasis	4.04e-05	0.000122	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	4.03e-05	0.000121	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—NFKBIA—psoriasis	4.02e-05	0.000121	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—APOE—psoriasis	3.98e-05	0.00012	CbGpPWpGaD
Adenosine triphosphate—AKT1—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	3.98e-05	0.00012	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—SOCS1—psoriasis	3.94e-05	0.000118	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—CAT—psoriasis	3.92e-05	0.000118	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—STAT3—psoriasis	3.92e-05	0.000118	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—NFKB1—psoriasis	3.92e-05	0.000118	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—NOS2—psoriasis	3.87e-05	0.000116	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	3.85e-05	0.000116	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—TYK2—psoriasis	3.83e-05	0.000115	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—VEGFA—psoriasis	3.8e-05	0.000114	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—SOCS1—psoriasis	3.78e-05	0.000114	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—TYK2—psoriasis	3.76e-05	0.000113	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—NOS2—psoriasis	3.71e-05	0.000112	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—SOCS1—psoriasis	3.69e-05	0.000111	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CYP2S1—psoriasis	3.69e-05	0.000111	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—GPCR downstream signaling—CXCL8—psoriasis	3.6e-05	0.000108	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—TYK2—psoriasis	3.6e-05	0.000108	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—TYK2—psoriasis	3.57e-05	0.000107	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—VEGFA—psoriasis	3.55e-05	0.000107	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—STAT3—psoriasis	3.52e-05	0.000106	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—SOCS1—psoriasis	3.5e-05	0.000105	CbGpPWpGaD
Adenosine triphosphate—ADCY1—GPCR downstream signaling—CXCL8—psoriasis	3.45e-05	0.000104	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—TYK2—psoriasis	3.43e-05	0.000103	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—VDR—psoriasis	3.39e-05	0.000102	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—TYK2—psoriasis	3.39e-05	0.000102	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—APOE—psoriasis	3.33e-05	0.0001	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—TYK2—psoriasis	3.29e-05	9.89e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CD8A—psoriasis	3.28e-05	9.84e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—CXCL8—psoriasis	3.27e-05	9.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—CD4—psoriasis	3.23e-05	9.71e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IFNG—psoriasis	3.21e-05	9.66e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—IL6—psoriasis	3.17e-05	9.54e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—TYK2—psoriasis	3.17e-05	9.53e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—LEP—psoriasis	3.16e-05	9.49e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—APOE—psoriasis	3.16e-05	9.49e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—NFKB1—psoriasis	3.15e-05	9.47e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HLA-B—psoriasis	3.15e-05	9.47e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Betamethasone—Hydrocortisone—psoriasis	3.14e-05	0.00197	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Hydrocortisone—psoriasis	3.14e-05	0.00197	CbGdCrCtD
Adenosine triphosphate—ADCY1—Signaling by GPCR—CXCL8—psoriasis	3.14e-05	9.43e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CD8A—psoriasis	3.1e-05	9.33e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—CD4—psoriasis	3.1e-05	9.33e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—CAT—psoriasis	3.1e-05	9.33e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—CD4—psoriasis	3.1e-05	9.32e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—IFNG—psoriasis	3.08e-05	9.26e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—IL6—psoriasis	3.06e-05	9.2e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—CD4—psoriasis	3.06e-05	9.2e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—APOE—psoriasis	3.05e-05	9.17e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—TYK2—psoriasis	3.04e-05	9.13e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—NFKB1—psoriasis	2.99e-05	8.98e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-B—psoriasis	2.99e-05	8.98e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—CD4—psoriasis	2.98e-05	8.95e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—NFKBIA—psoriasis	2.94e-05	8.84e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—IL6—psoriasis	2.93e-05	8.81e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HLA-A—psoriasis	2.92e-05	8.77e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Betamethasone—Dexamethasone—psoriasis	2.92e-05	0.00183	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Betamethasone—psoriasis	2.92e-05	0.00183	CbGdCrCtD
Adenosine triphosphate—ADRBK1—Signaling Pathways—LEP—psoriasis	2.91e-05	8.74e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—APOE—psoriasis	2.91e-05	8.74e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—PPARG—psoriasis	2.9e-05	8.73e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—JUN—psoriasis	2.89e-05	8.69e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—IL6—psoriasis	2.88e-05	8.66e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—CD4—psoriasis	2.87e-05	8.62e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.86e-05	8.6e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—VEGFA—psoriasis	2.86e-05	8.59e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Betamethasone—Triamcinolone—psoriasis	2.85e-05	0.00179	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Dexamethasone—Triamcinolone—psoriasis	2.85e-05	0.00179	CbGdCrCtD
Adenosine triphosphate—AKT1—Developmental Biology—STAT3—psoriasis	2.83e-05	8.51e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—VEGFA—psoriasis	2.81e-05	8.43e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—LEP—psoriasis	2.79e-05	8.38e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—APOE—psoriasis	2.79e-05	8.38e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CRP—psoriasis	2.78e-05	8.37e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—NFKB1—psoriasis	2.78e-05	8.36e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—JUN—psoriasis	2.78e-05	8.35e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-A—psoriasis	2.77e-05	8.32e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—IL6—psoriasis	2.76e-05	8.31e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.76e-05	8.28e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—CD4—psoriasis	2.75e-05	8.26e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—JUN—psoriasis	2.74e-05	8.24e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—IL6—psoriasis	2.74e-05	8.24e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—CAT—psoriasis	2.71e-05	8.15e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—VEGFA—psoriasis	2.71e-05	8.15e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—NFKBIA—psoriasis	2.71e-05	8.15e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Dexamethasone—Prednisone—psoriasis	2.71e-05	0.0017	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Prednisone—psoriasis	2.71e-05	0.0017	CbGdCrCtD
Adenosine triphosphate—AKT1—Disease—HLA-A—psoriasis	2.7e-05	8.1e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—TP53—psoriasis	2.69e-05	8.07e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—STAT3—psoriasis	2.68e-05	8.07e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—NFKB1—psoriasis	2.67e-05	8.04e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—NFKB1—psoriasis	2.67e-05	8.03e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HLA-DRB1—psoriasis	2.67e-05	8.02e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—JUN—psoriasis	2.66e-05	8.01e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—VEGFA—psoriasis	2.66e-05	7.99e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PPARG—psoriasis	2.66e-05	7.98e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Dexamethasone—Prednisolone—psoriasis	2.64e-05	0.00165	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Betamethasone—Prednisolone—psoriasis	2.64e-05	0.00165	CbGdCrCtD
Adenosine triphosphate—ABL1—Immune System—CRP—psoriasis	2.64e-05	7.93e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—NFKB1—psoriasis	2.64e-05	7.93e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—IL6—psoriasis	2.63e-05	7.9e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—NFKBIA—psoriasis	2.6e-05	7.81e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—NFKB1—psoriasis	2.56e-05	7.71e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—ICAM1—psoriasis	2.56e-05	7.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—NFKBIA—psoriasis	2.54e-05	7.63e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HLA-DRB1—psoriasis	2.53e-05	7.6e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—APOE—psoriasis	2.52e-05	7.56e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.5e-05	7.52e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—IL6—psoriasis	2.46e-05	7.39e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—TNF—psoriasis	2.45e-05	7.37e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—ICAM1—psoriasis	2.43e-05	7.29e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—APOE—psoriasis	2.41e-05	7.25e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TYK2—psoriasis	2.41e-05	7.24e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—NFKBIA—psoriasis	2.41e-05	7.24e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—STAT3—psoriasis	2.4e-05	7.23e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—SOCS1—psoriasis	2.39e-05	7.18e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—PPARG—psoriasis	2.36e-05	7.09e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—NOS2—psoriasis	2.34e-05	7.05e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—TNF—psoriasis	2.32e-05	6.98e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—STAT3—psoriasis	2.3e-05	6.93e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—TYK2—psoriasis	2.28e-05	6.84e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TYK2—psoriasis	2.22e-05	6.67e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—STAT3—psoriasis	2.22e-05	6.67e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—CXCL8—psoriasis	2.18e-05	6.56e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	2.14e-05	6.44e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TYK2—psoriasis	2.13e-05	6.4e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—STAT3—psoriasis	2.13e-05	6.4e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—TP53—psoriasis	2.12e-05	6.37e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—APOE—psoriasis	2.11e-05	6.33e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PPARG—psoriasis	2.1e-05	6.31e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CXCL8—psoriasis	2.1e-05	6.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—TYK2—psoriasis	2.08e-05	6.25e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—TP53—psoriasis	2.01e-05	6.04e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—CXCL8—psoriasis	1.98e-05	5.96e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—IL6—psoriasis	1.98e-05	5.94e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—TYK2—psoriasis	1.97e-05	5.93e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—JUN—psoriasis	1.95e-05	5.86e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IFNG—psoriasis	1.95e-05	5.85e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CXCL8—psoriasis	1.93e-05	5.81e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—TYK2—psoriasis	1.92e-05	5.77e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.89e-05	5.68e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CD4—psoriasis	1.88e-05	5.65e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—NFKB1—psoriasis	1.88e-05	5.64e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—IL6—psoriasis	1.87e-05	5.64e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CXCL8—psoriasis	1.85e-05	5.57e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IFNG—psoriasis	1.85e-05	5.55e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—IL6—psoriasis	1.84e-05	5.52e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PPARG—psoriasis	1.84e-05	5.52e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CARM1—psoriasis	1.8e-05	5.42e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—JUN—psoriasis	1.8e-05	5.4e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CD4—psoriasis	1.78e-05	5.36e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—APOE—psoriasis	1.76e-05	5.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—LEP—psoriasis	1.76e-05	5.3e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—IL6—psoriasis	1.76e-05	5.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—IL6—psoriasis	1.75e-05	5.25e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CD4—psoriasis	1.74e-05	5.22e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—NFKB1—psoriasis	1.73e-05	5.2e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—JUN—psoriasis	1.72e-05	5.18e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—VEGFA—psoriasis	1.7e-05	5.12e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—STAT3—psoriasis	1.69e-05	5.07e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—JUN—psoriasis	1.68e-05	5.06e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IL6—psoriasis	1.68e-05	5.05e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—NFKB1—psoriasis	1.66e-05	4.98e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—IL6—psoriasis	1.66e-05	4.98e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—NFKBIA—psoriasis	1.64e-05	4.93e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—NFKB1—psoriasis	1.62e-05	4.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—IL6—psoriasis	1.61e-05	4.84e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—JUN—psoriasis	1.6e-05	4.8e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—VEGFA—psoriasis	1.57e-05	4.72e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—STAT3—psoriasis	1.55e-05	4.67e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—IL6—psoriasis	1.55e-05	4.66e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—NFKB1—psoriasis	1.54e-05	4.62e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—VEGFA—psoriasis	1.5e-05	4.52e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—STAT3—psoriasis	1.49e-05	4.48e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—IL6—psoriasis	1.49e-05	4.47e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—STAT3—psoriasis	1.46e-05	4.38e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—STAT3—psoriasis	1.38e-05	4.15e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TYK2—psoriasis	1.34e-05	4.04e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—STAT3—psoriasis	1.34e-05	4.04e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TP53—psoriasis	1.29e-05	3.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TP53—psoriasis	1.19e-05	3.56e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IL6—psoriasis	1.18e-05	3.54e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CXCL8—psoriasis	1.17e-05	3.52e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TP53—psoriasis	1.14e-05	3.42e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—IL6—psoriasis	1.11e-05	3.35e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—CAT—psoriasis	1.11e-05	3.33e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—JUN—psoriasis	1.09e-05	3.27e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IL6—psoriasis	1.09e-05	3.26e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—NFKB1—psoriasis	1.05e-05	3.15e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IL6—psoriasis	1.04e-05	3.13e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL6—psoriasis	1.02e-05	3.06e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL6—psoriasis	9.64e-06	2.9e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—VEGFA—psoriasis	9.51e-06	2.86e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—STAT3—psoriasis	9.42e-06	2.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—IL6—psoriasis	9.39e-06	2.82e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—APOE—psoriasis	8.62e-06	2.59e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PPARG—psoriasis	7.5e-06	2.26e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TP53—psoriasis	7.19e-06	2.16e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL6—psoriasis	6.58e-06	1.98e-05	CbGpPWpGaD
